Latest from RegenMed

The latest results and evidence-based opinions from our global community of expert clinical Circle founders. Sign up today to receive new updates in your inbox each month.

November 10, 2021

Opinion: American Medical Society for Sports Medicine Position

This recently published position statement by the AMSSM summarily articulates the opportunities, risks and considerations for inclusion of orthobiologics ...

Read The Latest

November 10, 2021

Opinion: American Medical Society for Sports Medicine Position

This recently published position statement by the AMSSM summarily articulates the opportunities, risks and considerations for inclusion of orthobiologics ...

November 2, 2021

Plasmaconcept AG Prepares Circles for 2022 Post-Market Surveillance Strategy

Plasmaconcept AG, headquartered in Köln, Germany, has chosen Circles to conduct a multi-center, post-market surveillance study on its IM.P.A.C.T. platform ...

October 28, 2021

The Role of Real-World Evidence in Medical Product Distribution

The FDA states “Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis...

October 26, 2021

The Rising Role of Real-World Data and Real-World Evidence in Healthcare

According to the FDA, real-world data (RWD) are data relating to patient health status and/or the delivery of healthcare routinely collected from a variety...

October 6, 2021

Circles Chosen for Stem Cell-Enriched Lipofilling Patient Registry in Europe

In February 2020, RegenMed and StemMedical® signed a deal to create a Circle for their proprietary stem cell-enriched lipofilling method for breast, facial, ...

September 7, 2021

Introducing Regenerative Medicine Services of France

Christian Jorgensen, M.D., Ph.D, and Rosanna Feirrera Lopez, M.D., of CHU Montpellier, Loïc Le Coz, M.D., of CosmaGap, and Marion Bertrand-Marchand M.D., of ...

July 28, 2021

Multinational Comparison of SVF, PRP and BMAC in MSK

A research project to study the efficacy and safety of the use of platelet-rich plasma (PRP) and minimally manipulated cellular products (CVF and BMAC) for ...

July 14, 2021

PRP vs. Adipose in Knee OA, Argentina

Dr. Viña first selected a pathology (Knee OA) and patient-reported outcomes measure (KOOS + VAS) to begin gathering outcomes data from his patients ...

June 30, 2021

CELLS Webinar: Intraosseous PRP for Knee OA

We are proud to present the first CELLS Webinar, featuring Drs. Jose Miguel Catalán and Severiano Dos Anjos Vilaboa, as they describe their objectives ...

June 23, 2021

BMA in Sports Medicine: An Evidence-based Approach in NYC

Dr. Jaspal Singh, Vice-Chair and Associate Professor of Weill Cornell’s Department of Rehabilitation Medicine, specializes in providing comprehensive ...

June 16, 2021

New Webinar Series: PRP & BMAC

CELLS, or the “Clinical Evidence Leadership Lecture Series”, is back in a new digital format. Featuring clinician leaders from around the world, these ...

June 9, 2021

Improving Patient Engagement through Competition

Poor patient engagement can lead to non-compliance, adverse outcomes and substantial expense. (Lack of medicinal adherence costs the US healthcare system ...

May 19, 2021

Hyaluronic Acid v. HA+Autologous PRP For Knee OA

Together with his clinical colleagues in the Department of Orthopedic Surgery at the Singapore General Hospital, Professor Tay Boon Keng will be collecting ...

May 12, 2021

StemMedical’s Regenerative Aesthetics Registry

RegenMed closed an agreement with StemMedical A/S to construct and manage a private real-world evidence registry for regenerative aesthetic procedures for ...

May 5, 2021

Kenneth R. Zaslav, M.D. joins Regen Med C/SAB

RegenMed is honored that Kenneth R. Zaslav, M.D. has agreed to join the RegenMed C/SAB. Ken is well-known internationally for his leadership of major medical

April 28, 2021

FDA Enforcement of Regenerative Medicine Products

The FDA has recently confirmed definitive enforcement of its regulations regarding regenerative medicine products. Effective May 31, “discretionary” compliance

April 22, 2021

Severe OA, Intra-Osseous Injections, ESSKA Congress

Despite remarkable growth in value and international interest, the field of orthobiologics and regenerative medicine continues to rely upon “standards” derived

April 16, 2021

Platelets. Spin Optimization. Real World Study.

Recalling the deeds of Jonas Salk, David Pritchard, August Bier; it is admirable, but not so uncommon, that an enterprising scientist and/or clinician would ...

April 5, 2021

Using Real World Evidence to Compare Common Orthobiologic Clinical Options

Like many clinicians around the world treating musculoskeletal conditions, Dr. Lora Brown of St. Petersburg, Florida is ...

March 31, 2021

PRP for Lower Back Pain

Leading Physical Medicine and Rehabilitation (“PMR”) doctors affiliated with a large New York City hospital system are exploring the use of activated PRP ...

November 11, 2020

RegenMed Launches Regenerative Medicine Services of New York

RMSNY is a product-agnostic organization led by internationally recognized scientific and clinical thought leaders. Its clinical members ...

June 16, 2020

“Good Actors” in Regenerative Medicine

The power of regenerative medicine to heal, and prevent, a broad range of diseases and conditions has been recognized by major governments and medical ...

June 16, 2020

Employee Monitoring for COVID-19 is Multi-faceted

Infectious disease experts have expressed cautious optimism concerning efforts to develop a COVID-19 vaccine, but they also admit that there are no ...

June 10, 2020

10 Insights on Real World Evidence

Can Real World Evidence (RWE) now be considered a universal approach? For better or for worse, the stars seem to have aligned in its favor. In a world ...

June 9, 2020

The elective orthopedic surgery backlog and evidence-based regenerative medicine

Turnkey regenerative therapy standardization, remote patient follow-up and telemedicine solution designed ...

June 3, 2020

How to meet COVID challenges to MDR compliance while producing strategic growth benefits

According to the most recent KPMG/RAPS survey of 230 medical device manufacturers, 83% of respondents ...

April 27, 2020

Align Post Marketing Surveillance and Post Marketing Clinical Follow-up with Product Lifecycle Management

The new EU Medical Device Regulation (MDR), which was scheduled to come fully into force in May 2020 but ...

March 26, 2020

COVID-19 Patient Stratification Solution Proposed to Italian Ministry of Health

The Italian Ministry of Health, in collaboration with the World Health Organization, has put out a request for proposals for “telemedicine and home care ...

March 26, 2020

COVID-19 Ongoing Core Workforce Monitoring

As some countries begin to ease social distancing restrictions and many more consider such moves, the WHO is urging caution on the basis of current ...

March 26, 2020

COVID-19 Patient Stratification

The implications of the COVID-19 pandemic for hospitals, HCP’s and patients alike are manifold and far-reaching. Evidence-based patient stratification is an ...

January 16, 2020

Show Me the (Right) Data

Recent years have seen a deeper appreciation of which healthcare data have value, and which are nothing more than “digital snake oil”. (See this interview ...

December 18, 2019

Regen Med Attendance at the 17th Annual IFATS Conference

Regen Med recently attended the 17th Annual Conference of the International Federation for Adipose Therapeutics and Science (iFATS). The conference brought ...

December 5, 2019

Regen Med Attendance and Presentation at ASTAOR

Regen Med was honored to present alongside representatives of ESSKA and ESMA at ASTAOR’s International Sports Medicine Conference, held in ...

November 11, 2019

Regen Med Attendance at the 5th International Symposium Intra-Articular Treatment (ISIAT)

Regen Med was a sponsor and exhibitor at the recent ISIAT meeting in Lisbon Portugal, whose main theme ...

November 6, 2019

inCytes Teaser

Healthcare is about telling stories. Patients telling stories to doctors, doctors sharing stories with colleagues, and organizations building stories around ...

October 29, 2019

Regen Med Attendance at ICRS 2019 Summit in Vancouver

Regen Med was in attendance at the recent ICRS meeting in Vancouver, Canada, to connect with global scientists, clinicians, and industry in the pursuit of ...

September 14, 2019

“Big Data” versus the “Right Data”

Ever-more powerful algorithms are “crawling” through the petabytes of insurance claims, PROM’s, pharmacy, genome and other healthcare databases in an ...

September 14, 2019

Medical Societies Adding Value To Their Members, and Advancing Their Mission

Professional medical societies are committed to providing value to their members, and advancing science and ...

September 13, 2019

inCytes™: Making Data Work For the Physician

Clinical data collection need not be expensive, burdensome or irrelevant. On the contrary, it can lead to increased professional ...

September 13, 2019

Building REGAIN™ With Gruppo San Donato

As a major academic research institution, with an international reputation in musculoskeletal procedures, Istituto Ortopedico Galeazzi ...

September 13, 2019

The Power of A Network of Affiliated RMCE’s

Clinical, scientific and financial participation by accredited Member Physicians in two related entities, which together provide the ...

September 13, 2019

Better Online Ratings with Regular Follow-ups and Reports

Three key factors greatly affect whether your patients leave positive or negative ratings after a “Brazilian Butt Lift”, liposuction, or other ...

June 27, 2019

Real World Evidence

The concepts of Real World Data (“RWD”) and Real World Evidence (“RWE”) are now recognized by regulatory agencies, providers, payers and patients as ...

June 27, 2019

Regen Med Participation In An RMCE

Whether Regen Med co-invests as a shareholder, or separately allocates its own capital against a revenue share arrangement ...

June 27, 2019

Use of Real World Data and Evidence By Industry

Use inCytes™ For Real-World Data Collection, Post-Market Data Reports and Other Requirements. Two objectives shared by ...

June 27, 2019

Better Hip OA Outcomes Through E-Patient Monitoring and Reporting

Positive results for PRP treatments in Hip OA when compared to hyaluronic acid. Multiple ...

June 27, 2019

FDA HCT/P Guidelines: Understanding and Adherence

The FDA HCT/P regulations in this broad field involve three foundational concepts: autologous source, minimal manipulation and homologous use.

June 27, 2019

Clinical and Financial Benefits of An RMCE

Regenerative medicine, broadly defined, is one of this century’s major medical trends. Its “value” is estimated conservatively in excess ...

Contact RegenMed

Contact Us

RegenMed connects practitioners, patients and industry sponsors in the generation of actionable real-world evidence.

Quick Links
CirclesTechnologyLatestPrivacy Policy
Quick Links
AboutContactSign In
Copyright © 2021. Regenerative Medicine LLC. All rights reserved.